Pixium Vision, a French bioelectronics firm that develops bionic vision systems, said that its subretinal Prima system met the interim goals of a feasibility study involving patients with advanced dry age-related macular degeneration (AMD). The company will now prepare a clinical study due to start by the end of 2019. ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.